BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is an intensive cancer therapy entailing numerous physical, emotional, cognitive, and practical challenges. Patients' ability to adjust and cope with such challenges may depend on their ability to exert control over cognitive, emotional, and behavioral processes, that is, ability to self-regulate. Self-regulatory capacity is a limited resource that can be depleted or fatigued (i.e., "self-regulatory fatigue"), particularly in the context of stressful life events such as cancer diagnosis and treatment. PURPOSE: This is one of the first studies to examine self-regulatory fatigue in a cancer population. The current study aimed to (1) extract items for a specific scale of self-regulatory capacity and (2) examine the impact of such capacity on adaptation in patients with hematologic malignancies preparing for HSCT. METHODS: Factor analysis of four existing scales gauging psychological adjustment and well-being in 314 patients preparing for HSCT (63% male and 89% Caucasian) identified 23 items (α = 0.85) related to self-regulatory control or fatigue. This measure was then examined using existing clinical data obtained from 178 patients (57% male and 91% Caucasian) undergoing treatment for hematologic malignancies in relationship to quality of life, coping, and self-reported adherence to physicians' recommendations. RESULTS: Controlling for pain severity, physical fatigue, and depression, self-regulatory fatigue scores were incrementally associated with decreased quality of life, use of avoidance coping strategies, and decreased adherence to physicians' recommendations. CONCLUSION: These results emphasize the potential role of self-regulatory capacity in coping with and adjusting to hematologic cancers and future research is warranted.
BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is an intensive cancer therapy entailing numerous physical, emotional, cognitive, and practical challenges. Patients' ability to adjust and cope with such challenges may depend on their ability to exert control over cognitive, emotional, and behavioral processes, that is, ability to self-regulate. Self-regulatory capacity is a limited resource that can be depleted or fatigued (i.e., "self-regulatory fatigue"), particularly in the context of stressful life events such as cancer diagnosis and treatment. PURPOSE: This is one of the first studies to examine self-regulatory fatigue in a cancer population. The current study aimed to (1) extract items for a specific scale of self-regulatory capacity and (2) examine the impact of such capacity on adaptation in patients with hematologic malignancies preparing for HSCT. METHODS: Factor analysis of four existing scales gauging psychological adjustment and well-being in 314 patients preparing for HSCT (63% male and 89% Caucasian) identified 23 items (α = 0.85) related to self-regulatory control or fatigue. This measure was then examined using existing clinical data obtained from 178 patients (57% male and 91% Caucasian) undergoing treatment for hematologic malignancies in relationship to quality of life, coping, and self-reported adherence to physicians' recommendations. RESULTS: Controlling for pain severity, physical fatigue, and depression, self-regulatory fatigue scores were incrementally associated with decreased quality of life, use of avoidance coping strategies, and decreased adherence to physicians' recommendations. CONCLUSION: These results emphasize the potential role of self-regulatory capacity in coping with and adjusting to hematologic cancers and future research is warranted.
Authors: J E Epping-Jordan; B E Compas; D M Osowiecki; G Oppedisano; C Gerhardt; K Primo; D N Krag Journal: Health Psychol Date: 1999-07 Impact factor: 4.267
Authors: John R Wingard; Navneet S Majhail; Ruta Brazauskas; Zhiwei Wang; Kathleen A Sobocinski; David Jacobsohn; Mohamed L Sorror; Mary M Horowitz; Brian Bolwell; J Douglas Rizzo; Gérard Socié Journal: J Clin Oncol Date: 2011-04-04 Impact factor: 44.544
Authors: S McDiarmid; B Hutton; H Atkins; I Bence-Bruckler; C Bredeson; E Sabri; L Huebsch Journal: Bone Marrow Transplant Date: 2009-11-30 Impact factor: 5.483
Authors: Karen L Syrjala; Shelby L Langer; Janet R Abrams; Barry Storer; Jean E Sanders; Mary E D Flowers; Paul J Martin Journal: JAMA Date: 2004-05-19 Impact factor: 56.272
Authors: Canhua Xiao; Ronald C Eldridge; Jonathan J Beitler; Kristin A Higgins; Cynthia E Chico; Jennifer C Felger; Evanthia C Wommack; Tish Knobf; Nabil F Saba; Dong M Shin; Deborah W Bruner; Andrew H Miller Journal: Psychosom Med Date: 2020-06 Impact factor: 4.312
Authors: Canhua Xiao; Jonathan J Beitler; Kristin A Higgins; Toby Glazer; Linh Kha Huynh; Sudeshna Paul; Jennifer C Felger; Evanthia C Wommack; Nabil F Saba; Dong M Shin; Deborah W Bruner; Andrew H Miller Journal: Cancer Date: 2018-05-09 Impact factor: 6.860
Authors: Elin Børøsund; Cecilie Varsi; Matthew M Clark; Shawna L Ehlers; Michael A Andrykowski; Hilde Renate Sætre Sleveland; Anne Bergland; Lise Solberg Nes Journal: Transl Behav Med Date: 2020-08-07 Impact factor: 3.046
Authors: Doris Howell; Deborah K Mayer; Richard Fielding; Manuela Eicher; Irma M Verdonck-de Leeuw; Christoffer Johansen; Enrique Soto-Perez-de-Celis; Claire Foster; Raymond Chan; Catherine M Alfano; Shawna V Hudson; Michael Jefford; Wendy W T Lam; Victoria Loerzel; Gabriella Pravettoni; Elke Rammant; Lidia Schapira; Kevin D Stein; Bogda Koczwara Journal: J Natl Cancer Inst Date: 2021-05-04 Impact factor: 13.506
Authors: Elin Børøsund; Jelena Mirkovic; Matthew M Clark; Shawna L Ehlers; Michael A Andrykowski; Anne Bergland; Marianne Westeng; Lise Solberg Nes Journal: JMIR Form Res Date: 2018-09-06